Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.
Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.
Mateon Therapeutics, Inc. (OTCMKTS:MATN – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.03 and ...